Trials / Conditions / Relapsed Solid Tumor
Relapsed Solid Tumor
4 registered clinical trials studyying Relapsed Solid Tumor.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Study of STI-3031 in Patients With Selected Relapsed or Refractory Solid Tumors NCT04809012 | Sorrento Therapeutics, Inc. | Phase 2 |
| Completed | A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adul NCT04238819 | Eli Lilly and Company | Phase 1 / Phase 2 |
| Terminated | REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Saf NCT03690869 | Regeneron Pharmaceuticals | Phase 1 / Phase 2 |
| Unknown | Oxaliplatin for Children With Solid Tumors NCT01558453 | Sidnei Epelman | Phase 2 |